The 5-genomic mutation signature of our risk score model consisted of mutations in CREBBP, KEAP1, RAF1, STK11 and TP53. CREBBP, which encodes an acetyltransferase, has been frequently found to develop mutations in many tumor types (12–14). This evidence concerns the gene RAF1 and neoplasm.